Welcome to our dedicated page for Blend Labs SEC filings (Ticker: BLND), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Blend Labs, Inc. filings document the company’s digital banking origination business, operating results, governance, capital actions, and material corporate events. Form 8-K reports cover quarterly and annual financial results, supplemental Regulation FD materials, product and service disclosures, officer-transition matters, and board-authorized repurchases of Class A common stock.
Blend’s proxy materials describe annual meeting matters, board elections, executive compensation, stockholder voting procedures, and related governance disclosures. Recent filings also document completed corporate actions, including the sale of substantially all assets and liabilities of Title365 Company, Blend’s former title insurance business.
Blend Labs, Inc. (BLND) filed a Form 144 reporting a proposed sale of 20,000 common shares through Charles Schwab & Co., Inc. with an aggregate market value of $80,100.00. The shares represent a small portion of the company's outstanding common stock of 255,696,747 shares. The filing lists an approximate sale date of 09/05/2025. The shares were acquired on 06/10/2025 by restricted stock lapse from Blend Labs, Inc., and the consideration is listed as equity compensation. No related sales by the same person in the past three months are reported.
Blend Labs, Inc. (BLND) filing a Form 144 notifies the proposed sale of 101,429 shares of common stock with an aggregate market value of $405,980.00. The shares were acquired on 02/20/2024 by lapse of restricted stock as equity compensation from Blend Labs, Inc. The proposed sale is to be effected through Charles Schwab & Co., Inc. on or about 09/05/2025 on the NYSE. Total shares outstanding reported are 255,696,747. The filer certifies they do not possess undisclosed material adverse information about the issuer.
Form 144 notice for Blend Labs, Inc. (BLND) shows a proposed sale of 17,500 common shares via Charles Schwab & Co., Inc. with an aggregate market value of $70,063.00, to be sold on 09/05/2025 on the NYSE. The shares were acquired through restricted stock lapse events on 03/20/2024 (3,597 shares) and 05/20/2024 (13,903 shares) as equity compensation from Blend Labs, Inc. The filer also reported six prior sales by the same person between 07/03/2025 and 09/04/2025, totaling 28,000 shares and gross proceeds of $99,028.00. The notice includes the filer’s statement that they are not aware of undisclosed material adverse information.
Blend Labs insider notice: proposed sale of 4,000 shares. The Form 144 shows 4,000 shares of Blend Labs, Inc. common stock were acquired 02/20/2025 via a restricted stock lapse as equity compensation and are proposed for sale through Charles Schwab & Co., Inc. with an aggregate market value of $14,031 and an approximate sale date of 09/04/2025 on the NYSE. The filing also lists five insider sales by Winnie Ling in the past three months totaling 24,000 shares for $84,997 in gross proceeds, with individual sale dates and proceeds provided in the notice.
Oxana Tkach, Principal Accounting Officer of Blend Labs, Inc. (BLND), reported equity awards and tax-withheld shares related to vested restricted stock units. On 08/20/2025 the filing shows two grant-related transactions: 25,000 RSUs and 12,500 RSUs reported as acquisitions (transaction code M) that increased reported Class A common stock holdings to 164,972 shares before a tax-withholding disposition. A subsequent disposition of 10,763 shares (transaction code F) at a price of $3.01 was made to satisfy taxes, leaving 154,209 shares reported as beneficially owned. The derivative table shows RSU balances of 25,000 and 12,500 that convert one-for-one into Class A shares; the filing states these RSUs vest quarterly over four years and two years, respectively, and that shares were withheld to cover tax obligations.
Blend Labs insider filing: This Form 4 shows transactions by Winnie Ling, Head of Legal and People at Blend Labs (BLND). On 08/20/2025 Ms. Ling was credited with two grants of Restricted Stock Units (RSUs) totaling 81,250 units: 50,000 RSUs reported as vested and 31,250 RSUs newly awarded. A separate entry shows 32,637 shares were withheld to cover taxes in connection with RSU vesting, and a Rule 10b5-1 sale executed on 08/22/2025 disposed of 4,000 shares at $3.50 each. After the transactions the filing reports Ms. Ling beneficially owned 416,631 Class A shares.
Blend Labs insider filing shows grants and tax-withholding on RSUs for Head of Revenue. Brian Kneafsey, an officer and Director-level reporting person, received 75,000 restricted stock units (RSUs) on 08/20/2025 that convert one-for-one into Class A common stock. 33,689 shares were withheld to cover tax obligations at a price of $3.01 per share. Following the transactions, the filing reports 771,598 shares beneficially owned after the RSU grant and 737,909 shares after the withholding. The RSUs vest in equal quarterly installments over two years, subject to continued service.
Blend Labs insider Nima Ghamsari received restricted stock units (RSUs) totaling 500,000 Class A shares on 08/20/2025, comprised of 375,000 and 125,000 awards. Each RSU converts to one share of BLND Class A common stock. The filing shows withholding of 196,751 shares to cover taxes on vesting at a price noted of $3.01 per share, leaving the reporting person with 6,057,300 shares after the transactions. The larger 375,000 RSU grant vests quarterly over four years; the 125,000 RSU grant vests quarterly over two years, both conditioned on continued service. The form was signed by an attorney-in-fact on behalf of the reporting person.
Blend Labs, Inc. (BLND) filed a Form 144 notice for the proposed sale of 4,000 shares of common stock. The sale is to be executed through Charles Schwab & Co., Inc. on the NYSE with an approximate sale date of 08/22/2025 and an aggregate market value reported at $14,000. The shares were acquired on 02/20/2025 by restricted stock lapse from Blend Labs, Inc., with payment described as equity compensation. The filing reports 255,696,747 shares outstanding.
The filing also discloses four sales by Winnie Ling in the past three months: 8,000 shares on 07/03/2025 for $28,000; 4,000 on 07/10/2025 for $14,160; 4,000 on 07/24/2025 for $14,360; and 4,000 on 08/07/2025 for $14,477. The filer certifies no undisclosed material adverse information.
Insiders led by Brian N. Sheth and affiliated entities purchased a total of 683,677 shares of Blend Labs, Inc. (BLND) across three trading days. The purchases occurred on 08/18/2025 (38,585 shares at a weighted average price of $2.9736), 08/19/2025 (292,643 shares at $2.9993 weighted average) and 08/20/2025 (222,449 shares at $2.9601 weighted average). An additional 130,000 Class A shares are reported as held indirectly through a family trust. Following these transactions, the reporting group beneficially owned 3,676,919 Class A shares on an indirect basis. The filings identify Haveli Investments, Haveli Brooks Aggregator, Haveli Investments Software Fund I GP, Whanau Interests LLC, related management entities and Mr. Brian N. Sheth as reporting persons.